Status:
UNKNOWN
E-CLAIR: Efficiency and Cost-effectiveness of Artificial Intelligence Based Diabetic Retinopathy Screening in Flanders
Lead Sponsor:
Universitaire Ziekenhuizen KU Leuven
Conditions:
Diabetic Retinopathy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
To evaluate the efficiency and cost-effectiveness of an artificial intelligence based diabetic retinopathy screening program in Flanders
Detailed Description
The increase of diabetes patients is a 21st century global health challenge with a predicted 642 million people suffering from the disease by 2040. Diabetes mellitus is characterized by high blood sug...
Eligibility Criteria
Inclusion
- Diagnosis of diabetes mellitus
- Age \> 18 years old
- Patient is capable of giving informed consent
- Fluent in written and oral Dutch, or interpreter present
Exclusion
- \- History of treatment for diabetic retinopathy or diabetic macular edema (laser or intravitreal injections)
- Participant is contraindicated for imaging by fundus imaging systems used in the study
Key Trial Info
Start Date :
June 17 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
1200 Patients enrolled
Trial Details
Trial ID
NCT05391659
Start Date
June 17 2021
End Date
December 1 2022
Last Update
May 26 2022
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
UZA
Antwerp, Belgium
2
ZNA
Antwerp, Belgium
3
AZ sint Jan
Bruges, Belgium
4
AZ Turnhout
Turnhout, Belgium